Xeptiva Therapeutics

Biotechnology, Pet, Therapeutics, Veterinary
Founded in 2021-01-01
Montevideo, NA - Uruguay, Uruguay
http://xeptiva.com/
For Profit

About Xeptiva Therapeutics

Xeptiva Therapeutics is a veterinary biotechnology company that focuses on developing therapies for chronic inflammation conditions in companion animals. Its main products target chronic pain associated with osteoarthritis and atopic dermatitis in dogs. In addition, the company is developing therapies for the treatment of pain in horses and asthma in cats. Xeptiva's goal is to allow pets to live longer and healthier by targeting the underlying source of many chronic diseases.

Company Metrics

  • Employees: 1-10
  • Monthly Visits: None
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue:
  • Total Funding: 500000 USD
  • Last Funding: 500000 USD (Pre-Seed)
  • Funding Status: Seed

Technology Stack

Xeptiva Therapeutics actively uses None products in their tech stack.

Market Presence

Industries: Biotechnology, Pet, Therapeutics, Veterinary

Headquarters: Montevideo, NA - Uruguay, Uruguay